Arcadia Biosciences, an agricultural biotechnology company focused on products that benefit people and the environment, today announced that Don Emlay has joined the company as director of regulatory affairs and compliance.

Mr. Emlay brings more than 30 years of regulatory experience with consumer, industrial, and biotechnology-based plant products. During the past 17 years he has worked exclusively in the area of plant biotechnology. As vice president of regulatory affairs with Calgene, Inc. he provided leadership in the initial development of industry and regulatory guidelines for transgenic plants. He led the team of scientists, lawyers and regulatory specialists that brought the first genetically modified whole food through the USDA and FDA regulatory approval processes.

"Mr. Emlay is one of the agricultural biotechnology industry's regulatory pioneers," said Eric Rey, president of Arcadia Biosciences. "His deep experience in agricultural and food regulatory activities is an enormous asset to Arcadia as our product development activities continue to intensify."

Arcadia's current technology portfolio includes nitrogen-efficient plants; salt-tolerant plants; ricin-free castor plants; and plants that produce high levels of health-promoting omega-6 fatty acids. Mr. Emlay will be responsible for product planning and all regulatory activities related to these products.

Based in Davis, Calif., Arcadia Biosciences is an agricultural biotechnology company focused on the development of profitable agricultural products that improve the environment and enhance human health.